Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug ...

MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...

Cell therapy developer Cabaletta Bio (NASDAQ:CABA) traded higher on Monday after the U.S. FDA issued additional fast-track Designations for its lead candidate CABA-201 in autoimmune conditions, ...

If a wearable sleep tracker is not something you like to use you may be interested in the Respio a new sleep tracker which hides underneath your sheets and does not require you wear any special ...